Treatment of Proteinuria Due to Treatment Resistant or Treatment Intolerant Idiopathic Focal Segmental Glomerulosclerosis: A 2 Part Prospective Study of H.P. Acthar Gel (PODOCYTE)
Phase of Trial: Phase IV
Latest Information Update: 05 Mar 2018
At a glance
- Drugs Corticotropin (Primary)
- Indications Proteinuria
- Focus Therapeutic Use
- Acronyms PODOCYTE
- Sponsors Mallinckrodt plc
- 25 Sep 2017 Planned End Date changed from 1 Mar 2020 to 1 Jun 2021.
- 25 Sep 2017 Planned primary completion date changed from 1 Sep 2019 to 1 Jun 2021.
- 17 May 2016 Status changed from not yet recruiting to recruiting, according to a Mallinckrodt media release.